Skip to main content
Premium Trial:

Request an Annual Quote

Pierre Meulien

Pierre Meulien will step down as president and CEO of Genome Canada on July 17 to become the executive director of the Innovative Medicines Initiative in Belgium. Meulien has been with Genome Canada since October 2010. The organization has begun a global search for his successor. Cindy Bell, a member of Genome Canada's executive management team, will serve as its president and CEO on an interim basis.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.